NCT06426615 Connectivity and Neural Signatures of Consciousness in Unresponsive States
| NCT ID | NCT06426615 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Acute Brain Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The CONSCIUS study is a prospective, interventional study including patients with acute brain injury and impaired consciousness implanted with intracranial electrodes. The aim of the study is to investigate seizures and thalamocortical neural dynamics underlying behavioral unresponsiveness.
Eligibility Criteria
Inclusion Criteria: * 18 years old or older * Brain injury of any kind, with impaired consciousness or suspected seizures Exclusion Criteria: * \< 18 years old * Known pregnancy * Any condition that, in the judgement of the investigator, makes participation in the study unsafe or unfeasible (e.g., irreversible coagulopathy, large intracranial tumors, surgical technical problems…)
Contact & Investigator
Tom Theys, MD PhD
PRINCIPAL INVESTIGATOR
Universitaire Ziekenhuizen KU Leuven
Frequently Asked Questions
Who can join the NCT06426615 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06426615 currently recruiting?
Yes, NCT06426615 is actively recruiting participants. Contact the research team at steven.smeijers@uzleuven.be for enrollment information.
Where is the NCT06426615 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT06426615 clinical trial?
NCT06426615 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Tom Theys, MD PhD at Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 20 participants.